APSR2026-386

 
Late-Breaking
Submitted
Poster Presentation
 
AP12-010
P87
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1199738-46904-APSR壁报2_433154.pdf
Format: PDF Only
16. Interstitial Lung Disease
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

yaqun liu * Tianjin Medical University General Hospital Department of Respiratory and Critical Care Medicine tianjin China
jing zhang - Tianjin Medical University General Hospital Department of Respiratory and Critical Care Medicine tianjin China
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
yaqun
liu
842742960@qq.com
+85215324389347
31-40
China
Original Research
KL-6 levels in patients with interstitial lung disease Correlation analysis with lung function and inflammatory factors
Maximum 25 words
Abstract Content
Interstitial lung disease (ILD) is a heterogeneous group of lung disorders with insidious onset, poor prognosis, and challenges in early diagnosis and accurate assessment. This study aimed to investigate ELISA-detectable serum indicators in ILD patients and their clinical value, providing reliable laboratory evidence for ILD diagnosis, assessment and prognosis.间质性肺病(ILD)是一组起病隐匿、预后不良且早期诊断和准确评估困难的肺部疾病。本研究旨在探讨可检测于ELISA的血清标志物在ILD患者中的应用及其临床价值,为ILD的诊断、评估和预后提供可靠的实验室依据。间质性肺病(ILD)是一组起病隐匿、预后不良且早期诊断和准确评估困难的肺部疾病。本研究旨在探讨可通过ELISA检测的血清标志物在ILD患者中的应用及其临床价值,为ILD的诊断、评估和预后提供可靠的实验室依据。
Patients with ILD (including idiopathic pulmonary fibrosis [IPF] and connective tissue disease-associated ILD [CTD-ILD]) and healthy controls were enrolled. Fasting venous blood (5 mL) was collected from all subjects. The serum levels of Krebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), interleukin-6 (IL-6), matrix metalloproteinase-7 (MMP-7), and related autoantibodies (anti-Scl-70 and anti-PM-Scl) were measured by enzyme-linked immunosorbent assay (ELISA) . The expression differences of these indicators between the two groups were compared, and the correlations of each indicator with pulmonary function (diffusing capacity of the lung for carbon monoxide [DLCO], forced vital capacity [FVC]) and disease severity in ILD patients were analyzed.纳入了患有间质性肺病(ILD)的患者(包括特发性肺纤维化[IPF]和结缔组织病相关ILD[CTD-ILD])以及健康对照者。所有受试者均采集空腹静脉血(5 mL)。通过酶联免疫吸附试验(ELISA)检测各组患者的血清中克氏肺泡细胞6(KL-6)、表面活性蛋白D(SP-D)、白细胞介素-6(IL-6)、基质金属蛋白酶-7(MMP-7)以及相关自身抗体(抗Scl-70和抗PM-Scl)的水平。比较两组之间这些指标的表达差异,并分析各指标与ILD患者肺功能(一氧化碳弥散容积[DLCO]、用力肺活量[FVC])及疾病严重程度之间的相关性。纳入了患有间质性肺病(ILD)的患者(包括特发性肺纤维化[IPF]和结缔组织病相关ILD[CTD-ILD])以及健康对照者。所有受试者均采集空腹静脉血(5 mL)。通过酶联免疫吸附试验(ELISA)检测各组患者的血清中克氏肺泡细胞6(KL-6)、表面活性蛋白D(SP-D)、白细胞介素-6(IL-6)、基质金属蛋白酶-7(MMP-7)以及相关自身抗体(抗Scl-70和抗PM-Scl)的水平。比较两组之间这些指标的表达差异,并分析各指标与ILD患者肺功能(一氧化碳弥散容积[DLCO]、用力肺活量[FVC])及疾病严重程度之间的相关性。
Serum levels of KL-6, SP-D, IL-6, MMP-7 and positive rates of autoantibodies in ILD patients were significantly higher than controls (P<0.05). KL-6 and SP-D were negatively correlated with DLCO and FVC; IL-6 and MMP-7 were positively correlated with disease activity (P<0.05). The positive rates of anti-Scl-70 and anti-PM-Scl antibodies in CTD-ILD patients were significantly higher than those in IPF patients (P<0.05).间质性肺病(ILD)患者的血清KL-6、SP-D、IL-6、MMP-7水平以及自身抗体阳性率均显著高于对照组(<0.05)。KL-6和SP-D与DLCO和FVC呈负相关;IL-6和MMP-7与疾病活动度呈正相关(<0.05)。CTD-ILD患者中抗Scl-70和抗PM-Scl抗体的阳性率也显著高于IPF患者(<0.05)。 ILD 患者的 K-6、SP-D、IL-6、MMP-7 血清水平及自身抗体阳性率显著高于对照组(P<0.05)。KL-6和SP-D与DLCO和FVC呈负相关;IL-6和MMP-7与疾病活动呈正相关(P<0.05)。CTD-ILD患者中抗Scl-70和抗PM-Scl抗体的阳性率显著高于IPF患者(P<0.05)。间质性肺病(ILD)患者的血清KL-6、SP-D、IL-6、MMP-7水平以及自身抗体阳性率均显著高于对照组(<0.05)。KL-6和SP-D与DLCO和FVC呈负相关;IL-6和MMP-7与疾病活动度呈正相关(<0.05)。CTD-ILD患者中抗Scl-70和抗PM-Scl抗体的阳性率也显著高于IPF患者(<0.05)。间质性肺病(ILD)患者的血清KL-6、SP-D、IL-6、MMP-7水平以及自身抗体阳性率均显著高于对照组(<0.05)。KL-6和SP-D与DLCO和FVC呈负相关;IL-6和MMP-7与疾病活动度呈正相关(<0.05)。CTD-ILD患者中抗Scl-70和抗PM-Scl抗体的阳性率也显著高于IPF患者(<0.05)。
KL-6 and SP-D are core for ILD early diagnosis; IL-6 and MMP-7 indicate disease activity; autoantibodies assist CTD-ILD classification. Combined detection improves diagnostic and prognostic accuracy for clinical reference.KL-6和SP-D是ILD早期诊断的核心指标;IL-6和MMP-7可反映疾病活动度,自身抗体有助于CTD-ILD的分类。联合检测可提高临床参考的诊断与预后准确性。KL-6和SP-D是ILD早期诊断的核心指标;IL-6和MMP-7可反映疾病活动度,自身抗体有助于CTD-ILD的分类。联合检测可提高临床参考的诊断与预后准确性。联合检测可提高临床参考的诊断与预后准确性。
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
interstitial lung disease,diffusing capacity of the lung for carbon monoxide ,forced vital capacity
maximum 3 keywords and no abbreviations, separated by commas
 
394